PCCB
Basic information
Region (hg38): 3:136250340-136337896
Links
Phenotypes
GenCC
Source:
- propionic acidemia (Definitive), mode of inheritance: AR
- propionic acidemia (Definitive), mode of inheritance: AR
- propionic acidemia (Definitive), mode of inheritance: AR
- propionic acidemia (Supportive), mode of inheritance: AR
- propionic acidemia (Strong), mode of inheritance: AR
- propionic acidemia (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Propionic acidemia | AR | Biochemical; Cardiovascular | In acute episodes, acidosis and hypoglycemia correction, with IV carnitine are beneficial (hemodialysis may be required); Dietary (including protein restriction, to decrease propiogenic substrates) and medical (eg, l-carnitine, metronidazole, N-carbamoylglutamate) therapy may be beneficial; Liver transplant may be required in some individuals; Fasting should be avoided, and care should be taken in the setting of acute stressors; Individuals are at risk for manifestations such as cardiovascular aberrations, and surveillance may be beneficial | Allergy/Immunology/Infectious; Biochemical; Cardiovascular; Hematologic; Neurologic | 10502773; 17051315; 19238581; 20301313; 22593918; 22033733; 23053474; 30879957; 36395710 |
ClinVar
This is a list of variants' phenotypes submitted to
- Propionic acidemia (80 variants)
- not provided (14 variants)
- Inborn genetic diseases (2 variants)
- Abnormality of metabolism/homeostasis (1 variants)
- not specified (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PCCB gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 258 | 260 | ||||
missense | 13 | 40 | 261 | 320 | ||
nonsense | 19 | 14 | 33 | |||
start loss | 6 | |||||
frameshift | 30 | 30 | 65 | |||
inframe indel | 10 | 11 | ||||
splice donor/acceptor (+/-2bp) | 13 | 43 | 56 | |||
splice region | 3 | 16 | 63 | 2 | 84 | |
non coding | 12 | 193 | 24 | 230 | ||
Total | 83 | 127 | 290 | 457 | 24 |
Highest pathogenic variant AF is 0.000322
Variants in PCCB
This is a list of pathogenic ClinVar variants found in the PCCB region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-136250341-G-A | Propionic acidemia | Uncertain significance (Jan 12, 2018) | ||
3-136250342-G-A | Propionic acidemia | Uncertain significance (Jan 13, 2018) | ||
3-136250362-CCGGCACAGCAAAAATGGCGG-C | Propionic acidemia | Pathogenic (Sep 13, 2022) | ||
3-136250364-G-A | not specified | Likely benign (Feb 07, 2017) | ||
3-136250377-T-A | Pathogenic (Sep 14, 2012) | |||
3-136250377-T-C | Propionic acidemia | Pathogenic (Sep 12, 2022) | ||
3-136250377-T-G | Propionic acidemia | Pathogenic (Jul 19, 2023) | ||
3-136250377-TG-AA | Propionic acidemia | Pathogenic (Sep 15, 2023) | ||
3-136250376-A-ATGGCGGCGGCATTACGGG | Propionic acidemia | Uncertain significance (Aug 10, 2022) | ||
3-136250378-G-A | Propionic acidemia | Pathogenic (Dec 23, 2022) | ||
3-136250380-C-A | Propionic acidemia | Uncertain significance (Jan 06, 2022) | ||
3-136250380-C-T | Propionic acidemia | Uncertain significance (Apr 15, 2022) | ||
3-136250380-CGGCGGCATTACGGGT-C | Propionic acidemia | Uncertain significance (Feb 18, 2022) | ||
3-136250381-G-A | Propionic acidemia | Likely benign (Apr 25, 2022) | ||
3-136250381-G-C | Propionic acidemia | Likely benign (Mar 07, 2023) | ||
3-136250383-C-T | Propionic acidemia • Inborn genetic diseases | Uncertain significance (May 05, 2023) | ||
3-136250383-CG-C | Propionic acidemia | Pathogenic (Sep 12, 2022) | ||
3-136250384-G-A | Propionic acidemia | Likely benign (Oct 18, 2022) | ||
3-136250384-G-C | not specified | Likely benign (Dec 11, 2017) | ||
3-136250387-A-G | Propionic acidemia | Likely benign (Oct 15, 2023) | ||
3-136250388-T-C | Propionic acidemia | Likely benign (Jun 29, 2021) | ||
3-136250389-T-G | Propionic acidemia | Pathogenic/Likely pathogenic (Apr 14, 2023) | ||
3-136250391-C-G | Propionic acidemia | Uncertain significance (Mar 12, 2022) | ||
3-136250391-C-T | Propionic acidemia | Uncertain significance (Sep 01, 2021) | ||
3-136250392-G-A | Inborn genetic diseases | Uncertain significance (Aug 08, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PCCB | protein_coding | protein_coding | ENST00000469217 | 16 | 87591 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.53e-8 | 0.955 | 125672 | 0 | 76 | 125748 | 0.000302 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.867 | 353 | 310 | 1.14 | 0.0000172 | 3623 |
Missense in Polyphen | 137 | 136.23 | 1.0056 | 1609 | ||
Synonymous | -1.67 | 139 | 116 | 1.20 | 0.00000658 | 1118 |
Loss of Function | 2.00 | 17 | 28.5 | 0.596 | 0.00000159 | 331 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00147 | 0.00146 |
Ashkenazi Jewish | 0.0000992 | 0.0000992 |
East Asian | 0.000327 | 0.000326 |
Finnish | 0.000185 | 0.000185 |
European (Non-Finnish) | 0.000275 | 0.000273 |
Middle Eastern | 0.000327 | 0.000326 |
South Asian | 0.000164 | 0.000163 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Disease
- DISEASE: Propionic acidemia type II (PA-2) [MIM:606054]: Life- threatening disease characterized by episodic vomiting, lethargy and ketosis, neutropenia, periodic thrombocytopenia, hypogammaglobulinemia, developmental retardation, and intolerance to protein. {ECO:0000269|PubMed:10447268, ECO:0000269|PubMed:11749052, ECO:0000269|PubMed:12189489, ECO:0000269|PubMed:12559849, ECO:0000269|PubMed:15059621, ECO:0000269|PubMed:2154743, ECO:0000269|PubMed:8411997, ECO:0000269|PubMed:9683601}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Propanoate metabolism - Homo sapiens (human);Valine, leucine and isoleucine degradation - Homo sapiens (human);Glyoxylate and dicarboxylate metabolism - Homo sapiens (human);3-Methylglutaconic Aciduria Type I;Valine, Leucine and Isoleucine Degradation;2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency;Malonyl-coa decarboxylase deficiency;Malonic Aciduria;Isovaleric Aciduria;3-Methylcrotonyl Coa Carboxylase Deficiency Type I;Propionic Acidemia;Maple Syrup Urine Disease;Propanoate Metabolism;3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency;Isobutyryl-coa dehydrogenase deficiency;3-hydroxyisobutyric aciduria;3-hydroxyisobutyric acid dehydrogenase deficiency;Isovaleric acidemia;Methylmalonate Semialdehyde Dehydrogenase Deficiency;Methylmalonic Aciduria;Methylmalonic Aciduria Due to Cobalamin-Related Disorders;3-Methylglutaconic Aciduria Type IV;3-Methylglutaconic Aciduria Type III;Threonine and 2-Oxobutanoate Degradation;Beta-Ketothiolase Deficiency;Biotin transport and metabolism;Metabolism of lipids;propionyl-CoA degradation;Propionyl-CoA catabolism;Mitochondrial Fatty Acid Beta-Oxidation;Metabolism;Fatty acid metabolism;Propanoate metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Valine, leucine and isoleucine degradation;Valine Leucine Isoleucine degradation;2-oxobutanoate degradation;superpathway of methionine degradation
(Consensus)
Recessive Scores
- pRec
- 0.542
Intolerance Scores
- loftool
- 0.0993
- rvis_EVS
- 0.11
- rvis_percentile_EVS
- 62
Haploinsufficiency Scores
- pHI
- 0.166
- hipred
- Y
- hipred_score
- 0.694
- ghis
- 0.522
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.994
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Pccb
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Gene ontology
- Biological process
- biotin metabolic process
- Cellular component
- mitochondrion;mitochondrial matrix;cytosol
- Molecular function
- propionyl-CoA carboxylase activity;protein binding;ATP binding